BNP Paribas Knock-Out OMV/ DE000PG8T413 /
1/24/2025 4:47:06 PM | Chg.+0.020 | Bid5:25:48 PM | Ask5:25:48 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.920EUR | +2.22% | 0.910 Bid Size: 25,000 |
0.920 Ask Size: 25,000 |
OMV AG | 47.8475 EUR | 12/31/2078 | Put |
GlobeNewswire
3/26/2024
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16/2024
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center